ABSTRACT
INTRODUCTION
The primary squamous cell carcinoma is an uncommon tumor of the endometrium which diagnosis is based on pathological examination. Its etiopathogenesis remains unclear. Its therapeutic care stays controversy with poor prognostic.
We report the case of a patient of 67 years old, and we discuss diagnostic, therapeutic and prognostic features. 
CASE PRESENTATION
Mrs. BF 67 years old, married and has 5 children, 9 years since menopause, with no notion of taking oral contraception or Hormone replacement therapy. She reported no personal or family history of endometrial, breast, colon (Lynch syndrome) or ovarian cancer. The patient consults for spontaneous postmenopausal bleeding associated with hydrorrhea evolving for two years in context of deterioration of general condition with no other signs gynecological or extra gynecological including no associated urinary or gastrointestinal symptoms. The general examination is a patient with World Health Organization (WHO) score is 1.
Gynecological examination finds atrophic vulva (given the age of the patient). The examination with speculum find reddish bleeding originating from endocervix and a macroscopically normal appearance cervix. On vaginal examination: uterus of normal size, no mass or latero-uterine tenderness. Abdominal examination found a soft abdomen with no collateral venous circulation and no hepatosplenomegaly. The examination of breasts, lymph nodes and the rest of examination are within limits. Pelvic ultra sound: uterus with regular contours (103 / 70 millimeter), the presence of an intracavitary image of 56x70mm not vascularized with doppler and absence of intraperitoneal effusion (Figure 1 ).
Figure 1: ultra sound intracavitary image not vascularized with doppler
Hysteroscopy diagnosis: Taking all the uterine cavity whitish evoking endometrial neoplasia, an endometrial biopsy and curettage were done. Histology showed an adenocarcinoma endometroide grade 2.
Resonance Imaging: Mass intra cavity (75x80x81mm) with heterogeneous necrotic tissue appearance andendometrial implantation. The mass is responsible of a total myometrial invasion without crossing the serosa. It skims the endocervix down without invading it and stays away from the vagina. (Figure 2& The preoperative evaluation was unremarkable. The patient underwent a midline laparotomy exploring a uterus of normal size, the two appendages of the womb were unremarkable and nointraperitoneal effusion. Performing a total hysterectomy with adnexectomy and pelvic node dissection and multiple biopsies and peritoneal cytology samples. Histological study showed macroscopically burgeoning whitish tumor occupying the entire uterine cavity and infiltrating less than 50% of the thickness of the myometrium. Under the microscope, the sample An MRI check performed 4 months after the end of treatment showed a voluminous retroperitoneal and latero aortic mass measuring 105x100 mm. Patient was lost to follow up then deceased one year later
DISCUSSION
The primary squamous cell carcinoma of the endometrium is an extremely rare tumor, it has been reported less than 100 times in medical literature since its characterization in 1892. Fluhmann et al [1] highlighted in 1928, 3 diagnostic criteria of primary squamous cell carcinoma of the endometrium:
• Clinical and radiological aspects are not specific. In a literature review, a study led by Goodman et al. [5] , reported 8 cases of patients suffering from a The primary endometrial carcinoma, squamous cell (PESCC) in a series of 1182 patients treated for endometrial cancer at the Hospital (Massachusetts), he also reported in his study 56 cases previously described in the literature. Based on this study several characteristics PESCC were highlighted. The average age of women was 67 years (60 for endometrioidadenocarcinomas). 84% of patients were postmenopausal women. Many predisposing factors to the development of PESCC have been proposed: chronic inflammation, radiotherapy, the deficit or excess estrogen [6] . In 64 cases, obesity and the use of estrogen, that are well-established risk factors for endometrial carcinoma in general, have not been identified as factors predisposing to PESCC. However, nulliparity, with 36% of frequency, may be associated. The other preexisting condition in common with endometrial carcinoma was pyorrhea found in 31% of cases. The main clinical manifestations were post menopausal bleeding found in 44 patients (68%), vaginal discharge (28%), pelvic pain (17%), weight loss and pelvic mass sensation (6%). Distant metastases (1.5%) were observed in the urethral meatus, the vaginal orifice, the peritoneal space, the lung, liver, and brain [7] . Preoperative diagnosis of PESCC is often difficult, explaining in part lateness of patient cares by an average of 11.5 months. Only 50% of patients who underwent biopsy curettage before receiving definitive treatment had a preoperative diagnosis. Although surgery is the main therapy for the PESCC optimal, currently available data are insufficient to assess the effectiveness of the type of surgery (hysterectomy with pelvic lymphadenectomy alone or associated with lumbo-aortic node dissection) and the association of radiotherapy and chemotherapy. Our patient underwent a total hysterectomy with bilateral adnexectomy and pelvic node dissection followed by external radiotherapy and brachytherapy with no chemotherapy. The prognostic factors are the same as other types of endometrial carcinoma. All of stage I patients survived in addition to tumors limited to the uterus regardless of depth of myometrial invasion remains of good prognosis. However, the five patients with stage IV tumor, and most patients with stage III died despite adjuvant therapy. The importance of the grade has not been discussed in the literature. The presence of vascular emboli is an important risk factor for recurrence in endometrial carcinomas [8] , in the series of Goodman et al [5] all patients with vascular invasion died.In our case vascular emboli were absent.
CONCLUSION
The primary endometrial carcinoma, squamous cell (PESCC) is an extremely rare tumor and its pathogenesis remains unclear. There are no guidelines for how it should be treated: a first surgery with or without adjuvant therapy are offered. The prognosis seems depending on the stage of the tumor, the type of surgery and adjuvant treatment as well as the presence or absence of neoplastic emboli.
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